23:46:15
英国 United Kingdom
富时100指数周一下跌,表现不如欧洲同行,制药和生物技术股领跌。权重股阿斯利康股价下跌3.4%,此前该公司暂停了对剑桥研究中心的2亿英镑投资计划。葛兰素史克公司股价下跌超过1.5%。英国电信在任命了来自顶级投资者Bharti Global的两名董事会成员后,股价也下跌了2%以上,自去年以来上涨了45%。从好的方面来看,Sainsbury的股价飙升超过3.5%,达到四年来的最高点,此前该公司确认以不利条款为由结束了将Argos出售给京东的谈判。分析师表示,这家零售商仍对出售持开放态度,这可能会将注意力重新集中在其强大的食品业务上,并可能吸引新的收购者。投资者现在期待着本周在美国和英国举行的央行会议,以及周三公布的英国通胀数据,预计通胀率将保持在3.8%,为18个月来的最高水平。
The FTSE 100 fell on Monday, underperforming European peers, led by losses in the pharma and biotech stocks. Heavyweight AstraZeneca dropped 3.4% after pausing a planned £200 million investment in its Cambridge research centre. GlaxoSmithKline went down more than 1.5%. BT also slipped over 2% after appointing two board members from top investor Bharti Global, following a 45% rally since last year. On the upside, Sainsbury’s surged more than 3.5% to a four-year high after confirming it ended talks to sell Argos to JD.com, citing unfavorable terms. Analysts said the retailer remains open to a disposal, which could refocus attention on its strong food business and potentially attract new suitors. Investors are now looking ahead to this week’s central bank meetings in the US and UK, along with UK inflation data on Wednesday, forecast to hold at 3.8% year-on-year, an 18-month high.